Skip to search formSkip to main contentSkip to account menu

Johnson and Johnson

Known as: Johnson & Johnson 
health product manufacturer
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Microbial cocktails join fecal transplants in IBD treatment trials
787 disorder, is more complex and involves hostbacterial interactions. “A long list of bacteria has been [suggested as the cause… 
Review
2015
Review
2015
Assessing “First Mile” Supply Chain Factors Affecting Timeliness of School-Based Deworming Interventions: Supply and Logistics Performance Indicators
Background Between 2007 and 2012, Children Without Worms (CWW) oversaw the Johnson & Johnson (J&J) donation of Vermox… 
2014
2014
Novartis' lung cancer ALK inhibitor approved
2013
2013
J&J courts biotech in clusters
own “pretty substantial” budget, says Urban, who won’t elaborate. Rather than investing in competition with other business units… 
2010
2010
Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02
Abstract 859 Method: This study was addressed to patients with MM who were symptomatic and progressive following at least two… 
2010
2010
The lengthening handshake
Although mergers and acquisitions (M&As) failed to hit the heights some analysts had predicted in 2009, a new type of tiered… 
2010
2010
Johnson & Johnson Revives Interest in Respiratory Drugs Research
Johnson & Johnson (J&J), through its subsidiaries, has inked two successive deals for preclinical compounds to treat respiratory… 
2009
2009
Les fonds mutuels éthiques américains : la présence de croyances organisationnelles au cœur de la performance sociale et financière.
There are many ways to classify ethical mutual funds. One of them is to focus on the kinds of organizational beliefs we could… 
2008
2008
Johnson & Johnson Strengthens its Biosurgical Position by Acquiring Omrix
Johnson & Johnson (J&J) has gained a series of innovative biosurgical products with its acquisition of Omrix, its partner of five… 
2005
2005
An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
In this paper we describe an initial reproducibility study of 12 proprietary compounds followed by the assessment of 51 marketed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)